Delivery Order SPE2DB20D3303-SPE2DB25FA0KR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $14,787.00. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,323.56. This is a firm fixed price delivery order with an ultimate completion date of October 17, 2025, and represents a non-competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $72,449.45 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 19, 2025. This competitive award, issued without a set-aside designation, carries a firm fixed price and an ultimate completion date of September 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $15,720.75. This firm fixed-price delivery order, with an ultimate completion date of June 18, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the agency's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,097.65 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Eliquis 2.5 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $27,309.78. This firm fixed-price delivery order is scheduled for completion by July 11, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units) with a ceiling value of $13,260.56. This non-set-aside, competitively awarded delivery order is scheduled for completion by June 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $1,862.57. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 29, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $3,961.54 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this award reflects AmerisourceBergen's capability to compete in open...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA0KRDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,081.16 on June 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order is scheduled for completion by June 20, 2025, with fulfillment performed at the vendor's Conshohocken, Pennsylvania location. The award was competitively procured without set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver a wide range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies both brand-name and generic pharmaceuticals across multiple therapeutic domains to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/18/25 |